After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ENTA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Enanta Pharmaceuticals Inc is $179.57M. A total of 75898.0 shares were traded on the day, compared to an average of 172.52K shares.
In the most recent transaction, Luly Jay R. bought 45,000 shares of ENTA for 5.69 per share on Feb 12 ’25. After the transaction, the President and CEO now owns 846,638 company shares. In a previous transaction on Dec 06 ’24, Kieffer Tara Lynn sold 2,283 shares at 8.06 per share. ENTA shares that Chief Product Strategy Officer owns now total 29,305.
Among the insiders who sold shares, Luu Brendan disposed of 2,283 shares on Dec 06 ’24 at a per-share price of $8.06. This resulted in the Chief Business Officer holding 36,047 shares of ENTA after the transaction. In another insider transaction, Rottinghaus Scott T. sold 866 shares at $8.06 per share on Dec 06 ’24. Company shares held by the Chief Medical Officer now total 17,918.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ENTA has a high of $13.43 and a low of $4.09.
As of this writing, ENTA has an earnings estimate of -$1.05 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.91 per share and a lower estimate of -$1.19. The company reported an EPS of -$1.36 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ENTA’s latest balance sheet shows that the firm has $244.00M in Cash & Short Term Investments as of fiscal 2021. There were $5.33M in debt and $36.17M in liabilities at the time. Its Book Value Per Share was $3.71, while its Total Shareholder’s Equity was $399.43M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ENTA is Buy with a score of 4.14.
